What Happened?
Tarrytown, NY-based Progenics Pharmaceuticalshired Jane Sterling as Associate Director Human Resources
About the Company
Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. Progenics` first-in-class PSMA-targeted technology platform for prostate cancer includes an antibody drug conjugate therapeutic which completed a two-cohort phase 2 clinical trial and a small molecule imaging agent that has also completed a phase 2 trial. Among other assets in its pipeline of targeted radiotherapy and molecular imaging compounds is Azedra™, an ultra-orphan radiotherapy candidate currently in a phase 2 study under an SPA. Progenics’ first commercial product, RELISTOR® (methylnaltrexone bromide) for opioid-induced constipation, is partnered with and marketed by Salix Pharmaceuticals, Ltd., a Valeant Pharmaceuticals International, Inc.
About the Person
Jane Sterling is Associate Director Human Resources at Progenics Pharmaceuticals, Inc.. Sterling is responsible for various aspects of Human Resources function at Progenics Pharmaceuticals, Inc.. Previously, Sterling held various HR leadership roles in the industry.
Info Source
News
Short Profile